Dimethyl fumarate Newbury 240 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate newbury 240 mg enterokapsel, hård

newbury pharmaceuticals ab - dimetylfumarat - enterokapsel, hård - 240 mg - dimetylfumarat 240 mg aktiv substans; propylenglykol hjälpämne

Dimethyl fumarate Newbury 120 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate newbury 120 mg enterokapsel, hård

newbury pharmaceuticals ab - dimetylfumarat - enterokapsel, hård - 120 mg - dimetylfumarat 120 mg aktiv substans; propylenglykol hjälpämne

Dimethyl fumarate Sandoz 120 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate sandoz 120 mg enterokapsel, hård

sandoz a/s - dimetylfumarat - enterokapsel, hård - 120 mg - propylenglykol hjälpämne; dimetylfumarat 120 mg aktiv substans

Dimethyl fumarate Sandoz 240 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate sandoz 240 mg enterokapsel, hård

sandoz a/s - dimetylfumarat - enterokapsel, hård - 240 mg - propylenglykol hjälpämne; dimetylfumarat 240 mg aktiv substans

Dimetylfumarat Avansor 240 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimetylfumarat avansor 240 mg enterokapsel, hård

avansor pharma oy - dimetylfumarat - enterokapsel, hård - 240 mg - dimetylfumarat 240 mg aktiv substans; propylenglykol hjälpämne

Dimetylfumarat Avansor 120 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimetylfumarat avansor 120 mg enterokapsel, hård

avansor pharma oy - dimetylfumarat - enterokapsel, hård - 120 mg - propylenglykol hjälpämne; dimetylfumarat 120 mg aktiv substans

Dimethyl fumarate Glenmark 240 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate glenmark 240 mg enterokapsel, hård

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hård - 240 mg - natriumlaurilsulfat hjälpämne; natriumbensoat hjälpämne; propylenglykol hjälpämne; cetostearylalkohol hjälpämne; dimetylfumarat 240 mg aktiv substans

Dimethyl fumarate Glenmark 120 mg Enterokapsel, hård Suède - suédois - Läkemedelsverket (Medical Products Agency)

dimethyl fumarate glenmark 120 mg enterokapsel, hård

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hård - 120 mg - dimetylfumarat 120 mg aktiv substans; natriumlaurilsulfat hjälpämne; propylenglykol hjälpämne; natriumbensoat hjälpämne; cetostearylalkohol hjälpämne

Tysabri Union européenne - suédois - EMA (European Medicines Agency)

tysabri

biogen netherlands b.v. - natalizumab - multipel skleros - selektiva immunsuppressiva medel - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 och 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Vumerity Union européenne - suédois - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multipel skleros, skovvis förlöpande - immunsuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).